Akantior

Akantior is an eye medicine used in adults and children aged 12 years and older for the treatment of Acanthamoeba keratitis, a rare and serious eye infection that mainly affects people who wear contact lenses. Acanthamoeba keratitis is caused by a single-celled organism called Acanthamoeba that affects the cornea (the transparent layer in front of the eye that covers the pupil and iris). If left untreated, Acanthamoeba keratitis, can lead to severe complications, including vision loss or the need for corneal transplant. Acanthamoeba keratitis is rare, and Akantior was designated an ’orphan medicine’ (a medicine used in rare diseases) on 14 November 2007. Further information on the orphan designation can be found here: [EU/3/07/498](https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-07-498) Akantior contains the active substance polihexanide.